Reported Earlier, Crescent Biopharma Prices Public Offering Of 8,094,793 Ordinary Shares At $14.50 Per Share, Expects $125.0M In Gross Proceeds

Loading news article.

Reported Earlier, Crescent Biopharma Prices Public Offering Of 8,094,793 Ordinary Shares At $14.50 Per Share, Expects $125.0M In Gross Proceeds | WAPE

Reported Earlier, Crescent Biopharma Prices Public Offering Of 8,094,793 Ordinary Shares At $14.50 Per Share, Expects $125.0M In Gross Proceeds

Article summary

Related companies

Comments —